Oslo, Norway, 17 June 2020
Vistin Pharma ASA (OSE: VISTIN), as previously announced Vistin Pharma ASA will
be conducting the Extraordinary General Meeting on the 24 of June as a digital
meeting, through Skype. This is a precautionary measure to prevent the spread of
Covid-19 and to ensure the safety and wellbeing of our shareholders, employees
and other stakeholders. Therefore, there will be no opportunity for physical
presence. You may cast votes prior to the meeting or grant a proxy. Please refer
the notice for the EGM and appendices for further information on voting in
advance and proxies. Attached is a stepwise guide for how to attend the meeting.
The complete set of documents relating to the Extraordinary General Meeting are
available on www.vistin.com.
For further information, please contact:
Alexander Karlsen
CFO
+47 97 05 36 21
alexander.karlsen@vistin.com (mailto:alexander.karlsen@vistin.com)
This information is subject to the disclosure requirements pursuant to
section 5-12 of the Norwegian Securities Trading Act.